Funding Research
Research provides hope and saves lives
Research and Clinical Trials
Research will unlock different treatment options to provide younger patients with more than a one-size-fits-all path forward. Precision medicine helps identify what therapy will best target that person’s complex cancer diagnosis. And research in immunotherapy, whereby one’s own immune system becomes the weapon in the fight against cancer, is critical for better survival overall.
Dr. Winters
WillStrong is initially focusing on supporting the work of Amanda Winters, MD, PhD, who specializes in the treatment of leukemias and lymphomas, as well as pre-cancerous bone marrow diseases. Dr. Winters began her work in the research lab of Dr. Craig Jordan, a world-renowned expert on AML and leukemia stem cells. Dr. Winters pioneered the development of droplet digital PCR (ddPCR) for disease monitoring in AML patients and has expanded laboratory investigations of targeted therapies.
Dr. Winters’ long-term research goals are to more accurately identify patients who carry low-level AML in their bone marrow so they can get further treatment, and to develop more effective and less toxic therapy options for AML patients (adult and pediatric). At present, less than 60% of younger AML patients survive their diagnosis and many with life-long health challenges and some with life-limiting issues that arise from their original treatment for AML.
Children’s Hospital Colorado (CHCO)
Children’s Hospital Colorado is the only pediatric cancer center in the Rocky Mountain region. CHCO is one of the top children’s hospitals in the nation. Located adjacent to the University of Colorado and School of Medicine, CHCO is part of a unique collaboration between some of the best physician scientists/research facilities in the country.
Center for Cancer and Blood Disorders
The Center for Cancer and Blood Disorders (CCBD) at Childrens is ranked among the top 10 best pediatric oncology programs in the country. Their experts provide clinical care to more than 1,500 patients a year. The team at the CCBD is committed to a convergence of collaboration to bring better therapies to young cancer patients.
“You beat cancer by how you live, why you live, and in the manner in which you live.”
STUART SCOTT